Małgorzata Mimier-Janczak
Research Subjects
Małgorzata Mimier-Janczak has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Marta Misiuk-Hojło
Department of Ophthalmology , Wroclaw Medical University , Wroclaw , Poland , umed.wroc.pl
4 shared publications - Dorota Maria Kaczmarek
Ophthalmology Clinical Centre Spektrum, Wroclaw
3 shared publications - Radosław Kaczmarek
Department and Clinic of Ophthalmology, Wroclaw Medical University
3 shared publications - Krzysztof Proc
Department and Clinic of Rheumatology and Internal Medicine, University Hospital, Borowska Street 213, 50-556 Wroclaw, Poland
2 shared publications - Andrzej Grzybowski
Institute for Research in Ophthalmology, Foundation for Ophthalmology Development, Poznan, Poland
1 shared publication - Anna Turno-Kręcicka
Department of Ophthalmology, University Clinical Hospital, 50-556 Wrocław, Poland
1 shared publication
Latest Publications
- Open Access
- 31 March 2025
- Published by Medical Education in OphthaTherapy. Therapies in Ophthalmology
- Vol. 12 (1) , 35-38
Neuroprotection in glaucoma – what is the role of brimonidine?
Glaucoma is a chronic, multifactorial, progressive optic neuropathy and if left untreated, leads to total blindness. Damage to retinal ganglion cells and their axons in glaucoma may be caused by increased intraocular pressure, ischemia, oxidative stress, glutamate neurotoxicity, or deficiency of neurotrophic growth factor. Brimonidine is an α2-adrenergic receptor agonist, a drug commonly used to lower intraocular pressure. Its action is to inhibit the production of aqueous humor and increase its outflow by an unconventional (uveoscleral) route. The neuroprotective mechanism of action of brimonidine is believed to be related to the reduction of extracellular glutamate and blocking the activation of N-methyl-D-aspartate (NMDA) receptors, as well as the activation of brain-derived neurotrophic factor (BDNF protein) and fibroblast growth factor and their receptors, vascular modulation improving microcirculation, and regulation of cell survival and apoptosis signals. Studies have shown that 0.2% brimonidine protects retinal ganglion cells from death, not only in the mechanism of lowering IOP. The use of neuroprotective treatment of retinal ganglion cells is a promising route in glaucoma therapy.
- 31 March 2025
- Published by Medical Education in OphthaTherapy. Therapies in Ophthalmology
- Vol. 12 (1) , 35-38
Open AccessNeuroprotection in glaucoma – what is the role of brimonidine?
Glaucoma is a chronic, multifactorial, progressive optic neuropathy and if left untreated, leads to total blindness. Damage to retinal ganglion cells and their axons in glaucoma may be caused by increased intraocular pressure, ischemia, oxidative stress, glutamate neurotoxicity, or deficiency of neurotrophic growth factor. Brimonidine is an α2-adrenergic receptor agonist, a drug commonly used to lower intraocular pressure. Its action is to inhibit the production of aqueous humor and increase its outflow by an unconventional (uveoscleral) route. The neuroprotective mechanism of action of brimonidine is believed to be related to the reduction of extracellular glutamate and blocking the activation of N-methyl-D-aspartate (NMDA) receptors, as well as the activation of brain-derived neurotrophic factor (BDNF protein) and fibroblast growth factor and their receptors, vascular modulation improving microcirculation, and regulation of cell survival and apoptosis signals. Studies have shown that 0.2% brimonidine protects retinal ganglion cells from death, not only in the mechanism of lowering IOP. The use of neuroprotective treatment of retinal ganglion cells is a promising route in glaucoma therapy.
- Open Access
- 30 June 2024
- Published by Medical Education in OphthaTherapy. Therapies in Ophthalmology
- Vol. 11 (2) , 147-150
Latanoprost drops without added detergent in the treatment of glaucoma
Chronic nature of both the disease and its therapy forces ophthalmologists to choose the treatment with the lowest potential for adverse reactions, which may be caused by the active substance, excipient or preservative. Detergents used in ophthalmic drops include a derivative of macrogolglycerol hydroxystearate-40 (MGHS-40), which in in vitro tests showed pro-inflammatory and cytotoxic properties towards corneal epithelial cells, and this effect increased with increasing concentration and time. The analyzed observational study showed that latanoprost without MGHS-40 effectively reduces intraocular pressure, and the factors encouraging ophthalmologists to choose this preparation were good local tolerance and a simple composition (without detergents, preservatives and antioxidants), improving compliance. In the observational study, 82.3% received latanoprost without MGHS-40, and almost 60% started antiglaucoma treatment with this preparation.
- 30 June 2024
- Published by Medical Education in OphthaTherapy. Therapies in Ophthalmology
- Vol. 11 (2) , 147-150
Open AccessLatanoprost drops without added detergent in the treatment of glaucoma
Chronic nature of both the disease and its therapy forces ophthalmologists to choose the treatment with the lowest potential for adverse reactions, which may be caused by the active substance, excipient or preservative. Detergents used in ophthalmic drops include a derivative of macrogolglycerol hydroxystearate-40 (MGHS-40), which in in vitro tests showed pro-inflammatory and cytotoxic properties towards corneal epithelial cells, and this effect increased with increasing concentration and time. The analyzed observational study showed that latanoprost without MGHS-40 effectively reduces intraocular pressure, and the factors encouraging ophthalmologists to choose this preparation were good local tolerance and a simple composition (without detergents, preservatives and antioxidants), improving compliance. In the observational study, 82.3% received latanoprost without MGHS-40, and almost 60% started antiglaucoma treatment with this preparation.
- Open Access
Sudden Vision Loss as the First Sign of Sepsis—Bilateral Endogenous Endophthalmitis of Uncommon Capnocytophaga canimorsus Etiology
We present a case of bilateral endogenous endophthalmitis with an extremely rare etiology of Capnocytophaga canimorsus. A 42-year-old asplenic patient with bilateral deterioration of visual acuity presented to the Emergency Department. The sudden deterioration of visual acuity, which prompted the patient to visit the ophthalmologist, was the first sign of the onset of sepsis. The physicians’ attention, in addition to poor visual acuity and intense inflammation on ophthalmologic examination, was drawn to the reported flu-like symptoms. They were accompanied by high C-reactive protein results and abnormalities in echocardiography. A blood culture isolated the bacterium Capnocytophaga canimorsus. Immunocompromised patients are particularly susceptible to C. canimorsus infection. Endophthalmitis of this etiology has a very aggressive course, both ophthalmic and systemic. Therefore, quick diagnosis and initiation of adequate therapy are crucial.
Open AccessSudden Vision Loss as the First Sign of Sepsis—Bilateral Endogenous Endophthalmitis of Uncommon Capnocytophaga canimorsus Etiology
We present a case of bilateral endogenous endophthalmitis with an extremely rare etiology of Capnocytophaga canimorsus. A 42-year-old asplenic patient with bilateral deterioration of visual acuity presented to the Emergency Department. The sudden deterioration of visual acuity, which prompted the patient to visit the ophthalmologist, was the first sign of the onset of sepsis. The physicians’ attention, in addition to poor visual acuity and intense inflammation on ophthalmologic examination, was drawn to the reported flu-like symptoms. They were accompanied by high C-reactive protein results and abnormalities in echocardiography. A blood culture isolated the bacterium Capnocytophaga canimorsus. Immunocompromised patients are particularly susceptible to C. canimorsus infection. Endophthalmitis of this etiology has a very aggressive course, both ophthalmic and systemic. Therefore, quick diagnosis and initiation of adequate therapy are crucial.
- Open Access
- 12 June 2023
- Published by Termedia Sp. z.o.o. in Rheumatology
- Vol. 61 (3) , 1-8
Subclinical retinopathy in systemic lupus erythematosus patients – Optical Coherence Tomography study
Introduction:: The aim was to detect subclinical structural retinal abnormalities in optical coherence tomography (OCT) in ophthalmologically asymptomatic systemic lupus erythematosus (SLE) patients without signs of lupus retinopathy or drug toxicity in fundus examination and in OCT and to...
- 12 June 2023
- Published by Termedia Sp. z.o.o. in Rheumatology
- Vol. 61 (3) , 1-8
Open AccessSubclinical retinopathy in systemic lupus erythematosus patients – Optical Coherence Tomography study
Introduction:: The aim was to detect subclinical structural retinal abnormalities in optical coherence tomography (OCT) in ophthalmologically asymptomatic systemic lupus erythematosus (SLE) patients without signs of lupus retinopathy or drug toxicity in fundus examination and in OCT and to...
- Open Access
- 14 December 2022
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 11 (24) , 7417
Evaluation of Subclinical Retinal Disease in Patients Affected by Systemic Lupus Erythematosus with No Evidence of Ocular Involvement—An Optical Coherence Tomography Angiography Original Study
Lupus retinopathy is the second most common eye involvement in systemic lupus erythematosus (SLE), associated with significant visual deterioration and well-known negative prognostic factor for survival. Ocular manifestation in SLE, relating the retina, ranges from asymptomatic vascular involvement to vision devastating vascular occlusions. Subclinical microvascular changes are undetectable in slit lamp examination, hence are underdiagnosed. Optical coherence tomography angiography (OCTA) is a novel, easy to interpret and non-invasive technique that allows retinal vessels visualization. OCTA simplifies clinical approach and measures the severity of decreased perfusion. The aim of the study was to demonstrate the retinal vascularization in a subclinical stage of ocular involvement in a cohort of SLE patients. Thirty-three patients (57 eyes) diagnosed with SLE were enrolled into the study group and 31 healthy individuals (56 eyes) into the control group. Vessel density reduction in parafovea, inferior and nasal quadrants of superficial retinal capillary plexus in a cohort of SLE patients was found. Among study group kidney involvement was associated with further microvasculature reduction. Knowing that retinal involvement may precede other organs impairment, early detection of retinal impairment and use of OCTA as a screening modality, may decrease overall disease morbidity.
- 14 December 2022
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 11 (24) , 7417
Open AccessEvaluation of Subclinical Retinal Disease in Patients Affected by Systemic Lupus Erythematosus with No Evidence of Ocular Involvement—An Optical Coherence Tomography Angiography Original Study
Lupus retinopathy is the second most common eye involvement in systemic lupus erythematosus (SLE), associated with significant visual deterioration and well-known negative prognostic factor for survival. Ocular manifestation in SLE, relating the retina, ranges from asymptomatic vascular involvement to vision devastating vascular occlusions. Subclinical microvascular changes are undetectable in slit lamp examination, hence are underdiagnosed. Optical coherence tomography angiography (OCTA) is a novel, easy to interpret and non-invasive technique that allows retinal vessels visualization. OCTA simplifies clinical approach and measures the severity of decreased perfusion. The aim of the study was to demonstrate the retinal vascularization in a subclinical stage of ocular involvement in a cohort of SLE patients. Thirty-three patients (57 eyes) diagnosed with SLE were enrolled into the study group and 31 healthy individuals (56 eyes) into the control group. Vessel density reduction in parafovea, inferior and nasal quadrants of superficial retinal capillary plexus in a cohort of SLE patients was found. Among study group kidney involvement was associated with further microvasculature reduction. Knowing that retinal involvement may precede other organs impairment, early detection of retinal impairment and use of OCTA as a screening modality, may decrease overall disease morbidity.
- Open Access
- 29 June 2021
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 10 (13) , 2887
Optical Coherence Tomography Angiography as a New Tool for Evaluation of the Subclinical Retinal Involvement in Patients with Systemic Lupus Erythematosus—A Review
Knowing the proven relationship between lupus retinopathy and systemic changes and disease activity, it is crucial to find the possibility of early diagnosis of retinal changes at a subclinical level in order to provide faster medical intervention and protect the patient from irreversible changes in the eye and other organs. The aim of this review is an analysis of studies investigating early pathological changes in retinal vascularization obtained by optical coherence tomography angiography (OCTA) and their relationship to the systemic lupus erythematosus (SLE). A literature search was performed to identify all relevant articles, regarding detection of subclinical retinal changes using OCTA in systemic lupus erythematosus listed in PubMed database. Seven out of seven papers found showed a decrease in superficial capillary plexus in ocular asymptomatic patients diagnosed with SLE. A decrease in retinal vessel density measured by OCTA may be a good marker of SLE activity and poor prognosis. OCTA in a safe manner can give clinicians a new perspective on processes of vessel remodeling and answer the question of how SLE might impact the eye from a structural point of view. Adding OCTA to the standard diagnostic process of SLE patients, may detect systemic changes early and prevent further visual deterioration by stopping progression of lupus retinopathy.
- 29 June 2021
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 10 (13) , 2887
Open AccessOptical Coherence Tomography Angiography as a New Tool for Evaluation of the Subclinical Retinal Involvement in Patients with Systemic Lupus Erythematosus—A Review
Knowing the proven relationship between lupus retinopathy and systemic changes and disease activity, it is crucial to find the possibility of early diagnosis of retinal changes at a subclinical level in order to provide faster medical intervention and protect the patient from irreversible changes in the eye and other organs. The aim of this review is an analysis of studies investigating early pathological changes in retinal vascularization obtained by optical coherence tomography angiography (OCTA) and their relationship to the systemic lupus erythematosus (SLE). A literature search was performed to identify all relevant articles, regarding detection of subclinical retinal changes using OCTA in systemic lupus erythematosus listed in PubMed database. Seven out of seven papers found showed a decrease in superficial capillary plexus in ocular asymptomatic patients diagnosed with SLE. A decrease in retinal vessel density measured by OCTA may be a good marker of SLE activity and poor prognosis. OCTA in a safe manner can give clinicians a new perspective on processes of vessel remodeling and answer the question of how SLE might impact the eye from a structural point of view. Adding OCTA to the standard diagnostic process of SLE patients, may detect systemic changes early and prevent further visual deterioration by stopping progression of lupus retinopathy.
- Open Access
- 7 February 2019
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 8 (2) , 206
Evaluation of the Association between the Risk of Central Retinal Artery Occlusion and the Concentration of Environmental Air Pollutants
The purpose of the retrospective, population-based study was to assess the relationship between the risk of central retinal artery occlusion (CRAO) and the level of air pollutants. This study identified 2.272 cases of newly diagnosed CRAO registered in the Polish National Health Service database. The study authors gathered hourly ambient concentrations of particulate matter—PM 2.5, PM 10, benzene, carbon monoxide, nitrogen dioxide, ozone, and sulfur dioxide from pollution monitoring stations. Data on average daily temperature and atmospheric pressure were also obtained. In the statistical analyses, single- and multi-factor Poisson negative binomial regression models were carried out, controlling also for ambient temperature and atmospheric pressure with seasonality set at a level of 4. This study has shown a positive association between CRAO onset and short-term, daily changes in PM 10, NO2, SO2, O3, and CO concentrations, as well as with air temperature, in the days preceding the diagnosis.
- 7 February 2019
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 8 (2) , 206
Open AccessEvaluation of the Association between the Risk of Central Retinal Artery Occlusion and the Concentration of Environmental Air Pollutants
The purpose of the retrospective, population-based study was to assess the relationship between the risk of central retinal artery occlusion (CRAO) and the level of air pollutants. This study identified 2.272 cases of newly diagnosed CRAO registered in the Polish National Health Service database. The study authors gathered hourly ambient concentrations of particulate matter—PM 2.5, PM 10, benzene, carbon monoxide, nitrogen dioxide, ozone, and sulfur dioxide from pollution monitoring stations. Data on average daily temperature and atmospheric pressure were also obtained. In the statistical analyses, single- and multi-factor Poisson negative binomial regression models were carried out, controlling also for ambient temperature and atmospheric pressure with seasonality set at a level of 4. This study has shown a positive association between CRAO onset and short-term, daily changes in PM 10, NO2, SO2, O3, and CO concentrations, as well as with air temperature, in the days preceding the diagnosis.